Do white matter hyperintensities on MRI matter clinically?

BMJ (Online)

Volumn 341, Issue 7767, 2010, Pages 259-

  Wallin, Anders ^a   Fladby, Tormod ^b  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HYALIN; MYELIN; PROTEIN;

ALZHEIMER DISEASE; ARTERIOLE; ARTERIOLOSCLEROSIS; ATHEROSCLEROSIS; BLOOD VESSEL TONE; BLOOD VESSEL WALL; BRAIN BLOOD VESSEL; COGNITIVE DEFECT; DEMENTIA; DISEASE COURSE; EDITORIAL; GAIT DISORDER; MEMORY DISORDER; MORTALITY; NERVE DEGENERATION; NERVE FIBER; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; RISK FACTOR; SCREENING; TISSUE INJURY; VASCULAR AMYLOIDOSIS; WHITE MATTER;

CEREBROVASCULAR DISORDERS; DEMENTIA, VASCULAR; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MICROCIRCULATION; STROKE;

EID: 77955343549     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c3400     Document Type: Editorial

References (11)

1. Vermeer SE, Longstreth WT Jr, Koudstaal PJ. Silent brain infarcts: a systematic review. Lancet Neurol 2007;6:611-9.[CrossRef][Web of Science][Medline]
2. Wen W, Sachdev PS, Li JJ, Chen X, Anstey KJ. White matter hyperintensities in the forties: their prevalence and topography in an epidemiological sample aged 44-48. Hum Brain Mapp 2009;30:1155-67. [CrossRef][Web of Science][Medline]
3. Inzitari D, Pracucci G, Poggesi A, Carlucci G, Barkhof F, Chabriat H, et al; LADIS Study Group. Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort. BMJ 2009;339:b2477. [Abstract/Free Full Text]
4. Debette S, Markus HS. The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis. BMJ 2010;341:c3666.[Abstract/Free Full Text]
5. De Reuck J. The cortico-subcortical arterial angio-architecture in the human brain. Acta Neurol Belg 1972;72:323-9.[Medline]
6. Pantoni L, Lammie A. Cerebral small vessel disease: pathological and pathophysiological aspects in relation to vascular cognitive impairment. In: Erkinjuntti T, Gauthier S, eds. Vascular cognitive impairment. Martin Dunitz, 2002:115-33.
7. Roman G, Erkinjuntti T, Wallin A, Pantoni L, Chui H. Subcortical ischemic vascular dementia. Lancet Neurol 2002;1:426-36.[CrossRef][Web of Science][Medline]
8. Zhan W, Zhang Y, Mueller SG, Lorenzen P, Hadjidemetriou S, Schuff N, et al. Characterization of white matter degeneration in elderly subjects by magnetic resonance diffusion and FLAIR imaging correlation. Neuroimage 2009;47(suppl 2):T58-65.[CrossRef][Web of Science][Medline]
9. Jonsson M, Zetterberg H, van Straaten E, Lind K, Syversen S, Edman A, et al. Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study. Eur J Neurol 2010;17:377-82.[CrossRef][Web of Science][Medline]
10. Carmeli D, DeCarli C, Swan GE, Jack LM, Reed T, Wolf PA, et al. Evidence for generic variance in white matter hyperintensity volume in normal elderly male twins. Stroke 1998;29:1177-81. [Abstract/Free Full Text]
11. Schmidt R, Scheltens P, Erkinjuntti T, Pantoni L, Markus HS, Wallin A, et al. White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease. Neurology 2004;63:139-44. [Abstract/Free Full Text]